Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

The remarkable efficacy of new diabetes and weight loss medicines like Ozempic and Mounjaro have been one of the biggest health stories of recent years. Despite rising rates of diabetes and obesity, ...

CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

Rybelsus (semaglutide) is the first GLP-1 agonist drug that can be dosed orally, and is Novo Nordisk's third drug in the class after daily injectable Victoza (liraglutide) and weekly shot Ozempic ...

The drug is a higher-dose formulation of Novo Nordisk's big-selling diabetes therapy Victoza ... fever injection is set to prevent suffering in millions of people. Dengvaxia is the first ever ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

Throughout this earnings release, we make a number of "forward-looking statements," including statements that are within the meaning of Section 27A of the Securities Act of 1933, as amended ...

Even under the best of circumstances, remembering to take a daily pill can be a challenge. For someone living with ...

"It has taken us quite a bit of time, but we're making good progress and we're stoked on it!" "We want to thank you guys for all your great responses on who we should tour with and where we should ...

Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...

It's been a long time." In the meantime, you can check out some footage of Trouble playing their first show since 2023 (and second this decade overall) below. The show took place on January 25 at ...